论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Chang H, Song J, Wu J, Zhang Y
Received 20 July 2018
Accepted for publication 17 October 2018
Published 15 November 2018 Volume 2018:11 Pages 8165—8173
DOI https://doi.org/10.2147/OTT.S180938
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Dr Sanjeev Srivastava
Purpose: E2F
transcription factor 8 (E2F8 ) is a novel member of the E2F family, but its
function in esophageal squamous cell carcinoma (ESCC) remains unclear. This
study aimed to research the function of E2F8 in ESCC.
Materials and methods: We used
quantitative real-time PCR and Western blot analyses to detect the expression
pattern of E2F8 in ESCC. The effects of E2F8 on proliferation were investigated by Cell
Counting Kit-8, 5-ethynyl-2′-deoxyuridine, and colony formation assays. We also
confirmed the function of E2F8 in vivo.
Results: E2F8
expression was upregulated in ESCC, and promoted cell proliferation and
influenced the expression of CCND1/p21. Downregulation of E2F8 expression
inhibited cell proliferation in vivo.
Conclusion: E2F8 was
identified as a new potential oncogene in ESCC.
Keywords: E2F8 , cell cycle,
ESCC, cell proliferation
